A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease

Conor Owens‐Walton(University of Southern California), Talia M. Nir(University of Southern California), Sarah Al–Bachari(Lancaster University), Sonia Ambrogi(Fondazione Santa Lucia), Tim Anderson(Canterbury Health Laboratories), Ítalo Karmann Aventurato(Universidade Estadual de Campinas (UNICAMP)), Fernando Cendes(Universidade Estadual de Campinas (UNICAMP)), Yao-Liang Chen(Chang Gung Memorial Hospital), Valentina Ciullo(Fondazione Santa Lucia), Phil Cook(University of Pennsylvania), John C. Dalrymple‐Alford(University of Canterbury), Michiel F. Dirkx(Radboud University Nijmegen), Jason Druzgal(University of Virginia), Hedley Emsley(Lancashire Teaching Hospitals NHS Foundation Trust), Rachel Guimarães(Universidade Estadual de Campinas (UNICAMP)), Hamied Haroon(Manchester Academic Health Science Centre), Rick C. Helmich(Radboud University Nijmegen), Michele T. Hu(University of Oxford), Martin E. Johansson(Radboud University Nijmegen), Ho Bin Kim(Stanford University), Johannes Klein(University of Oxford), Max A. Laansma(Amsterdam Neuroscience), Katherine E. Lawrence(University of Southern California), Christine Löchner(South African Medical Research Council), Clare E. Mackay(University of Oxford), Corey T. McMillan(University of Pennsylvania), Tracy R. Melzer(University of Canterbury), Leila Nabulsi(University of Southern California), Benjamin T. Newman(University of Virginia), Peter Opriessnig(Medical University of Graz), Laura M. Parkes(Manchester Academic Health Science Centre), Clelia Pellicano(Fondazione Santa Lucia), Fabrizio Piras(Fondazione Santa Lucia), Federica Piras(Fondazione Santa Lucia), Lukas Pirpamer(Medical University of Graz), Toni L. Pitcher(New Zealand Brain Research Institute), Kathleen L. Poston(Stanford University), Annerine Roos(South African Medical Research Council), Lucas Scárdua Silva(Universidade Estadual de Campinas (UNICAMP)), Reinhold Schmidt(Medical University of Graz), Petra Schwingenschuh(Medical University of Graz), Marian Shahid(Stanford University), Gianfranco Spalletta(Fondazione Santa Lucia), Dan J. Stein(South African Medical Research Council), Sophia I. Thomopoulos(University of Southern California), Duygu Tosun(University of California, San Francisco), Chih‐Chien Tsai(Chang Gung University), Odile A. van den Heuvel(Amsterdam University Medical Centers), Eva M. van Heese(Amsterdam University Medical Centers), Daniela Vecchio(Fondazione Santa Lucia), Julio E. Villalón‐Reina(University of Southern California), Chris Vriend(Amsterdam Neuroscience), Jiun‐Jie Wang(Ming Chi University of Technology), Yih‐Ru Wu(Chang Gung University), Clarissa Lin Yasuda(Universidade Estadual de Campinas (UNICAMP)), Paul M. Thompson(University of Southern California), Neda Jahanshad(University of Southern California), Ysbrand D. van der Werf(Amsterdam University Medical Centers)
npj Parkinson s Disease
August 11, 2024
Cited by 24Open Access
Full Text

Abstract

The progression of Parkinson's disease (PD) is associated with microstructural alterations in neural pathways, contributing to both motor and cognitive decline. However, conflicting findings have emerged due to the use of heterogeneous methods in small studies. Here we performed a large diffusion MRI study in PD, integrating data from 17 cohorts worldwide, to identify stage-specific profiles of white matter differences. Diffusion-weighted MRI data from 1654 participants diagnosed with PD (age: 20-89 years; 33% female) and 885 controls (age: 19-84 years; 47% female) were analyzed using the ENIGMA-DTI protocol to evaluate white matter microstructure. Skeletonized maps of fractional anisotropy (FA) and mean diffusivity (MD) were compared across Hoehn and Yahr (HY) disease groups and controls to reveal the profile of white matter alterations at different stages. We found an enhanced, more widespread pattern of microstructural alterations with each stage of PD, with eventually lower FA and higher MD in almost all regions of interest: Cohen's d effect sizes reached d = -1.01 for FA differences in the fornix at PD HY Stage 4/5. The early PD signature in HY stage 1 included higher FA and lower MD across the entire white matter skeleton, in a direction opposite to that typical of other neurodegenerative diseases. FA and MD were associated with motor and non-motor clinical dysfunction. While overridden by degenerative changes in the later stages of PD, early PD is associated with paradoxically higher FA and lower MD in PD, consistent with early compensatory changes associated with the disorder.


Related Papers

No related papers found

Powered by citation graph analysis